Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • November 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»World»Philippines FDA approves first ever generic version of Pfizer anti-Covid pill
    World

    Philippines FDA approves first ever generic version of Pfizer anti-Covid pill

    By January 26, 2022No Comments2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Manila (Philippines), January 25: The Philippines Food and Drug Administration (FDA) has approved the world’s first generic version of Pfizer’s anti-Coronavirus pill Paxlovid, just days after the original was granted Emergency Use Authorisation (EUA) by the US FDA.

    The Philippines FDA has approved the department of health’s application for a compassionate special permit application for the first generic version of Paxlovid that has been launched by Beximco Pharmaceuticals, a leading generic drugmaker from Bangladesh.

    Philippines-based Pharmaceutical company Biocare Lifesciences Inc would be the distributor and importer of a generic drug, which would be sold under the brand name Bexovid in the Philippines.

    According to Pfizer, the risk of hospitalisation or death is reduced by 89% when Paxlovid is given within three days of the onset of symptoms and by 88% when given within five days of the onset of symptoms. The treatment, a combination of Nirmatrelvir and Ritonavir tablets, is given together twice a day for five days and is recommended for treatment of mild to moderate cases of Covid-19.

    Pfizer data also suggests the drug remains effective against the faster-spreading Omicron variant of the Coronavirus, which is driving the latest surge in Covid-19 cases globally.

    “The approval by the Philippines FDA will make Bexovid accessible to Covid-19 patients in the country and add another treatment protocol to the existing drugs. We plan to import 20,000 to 30,000 courses of Bexovid initially and expect the supplies to begin in the first week of February. Bexovid is expected to be priced 50-60% cheaper than the original Pfizer drug, making it an affordable option,” said Dileep Tiwari, Managing Director, Biocare Lifesciences, during an interview with CNN.

    Bexovid is recommended as an at-home treatment to help reduce the severity of the infection. The drug has the potential to eliminate many hospitalizations, thus helping reduce the strain on the healthcare infrastructure.

    “Bexovid is not meant for patients who are hospitalised. Any patient who is Covid-19 positive can buy the drug from hospitals once supplies begin,” said Mr. Tiwari in a CNN interview.

    Separately, Bangladesh’s Directorate General of Drug Administration has also granted EUA for Bexovid to treat mild-to-moderate Covid-19 cases in patients aged 12 and above.

    world
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Egypt’s Jameel Finance becomes Intellect’s latest client for its eMACH.ai lending platform

    October 22, 2026

    Haji Syed Salman Chishty Represents Ajmer Sharif and India at the 33rd International Law and Religion Symposium, BYU, USA

    October 13, 2026

    Starbucks closes underperforming stores in North America, announces first GCC in India amid push for profitability, efficiency

    September 26, 2026

    Comments are closed.

    Recent Post
    • Pan IIT Alumni India Welcomes PM Modi’s Visit to IIT Kharagpur for Platinum Jubilee Celebrations
    • Kingston Debuts at Embedded World India, Deepening Its B2B Push in India’s Enterprise and Industrial Markets
    • HRH Next Services Reports H1 FY27 Results
    • ‘Mere Mahavir 3.1 – Mahavir Nirvana Katha’ Concludes on a Grand Spiritual Note at Bharat Mandapam
    • HydraSure’s Gen Z Team Turns GTA VI Launch Day Into a Giveaway – Planned and Live in 24 Hours
    • Heart and Lung Transplant Recipients Share Stories of a New Life at KIMS Patient Meet in Indore
    • Rahul Gupta: 10 Years of Selfless Service, Compassion and Humanity
    • Vijay Arora Announces Sataack 50, a Professional Tennis-Ball Cricket League for Men and Women

    Type above and press Enter to search. Press Esc to cancel.